Author(s): Crossingham I.; Evans D.J.W.; Halcovitch N.R.; Marsden P.A.
Source: Cochrane Database of Systematic Reviews; Feb 2017; vol. 2017 (no. 2)
Publication Date: Feb 2017
Publication Type(s): Journal: Review
Abstract:Background: Asthma is a condition of the airways affecting more than 300 million adults and children worldwide. National and international guidelines recommend titrating up the dose of inhaled corticosteroids (ICS) to gain symptom control at the lowest possible dose because long-term use of higher doses of ICS carries a risk of systemic adverse events. For patients whose asthma symptoms are controlled on moderate or higher doses of ICS, it may be possible to reduce the dose of ICS without compromising symptom control.
The following databases were searched:
EMBASE, MEDLINE, PsycINFO, BNI, CINAHL,
to find ELHT staff publications
Archives - past 2 years
Your Specialty or Professional Group